Humanization strategies for an anti-idiotypic antibody mimicking HIV-1 gp41.
Mader
A
A
Department of Biotechnology, Institute for Applied Microbiology, BOKU-University of Natural Resources and Applied Life Sciences, Muthgasse 11, A-1190 Vienna, Austria.
Kunert
R
R
D016915:AIDS Vaccines / Q000737:chemistry* / Q000378:metabolism; D000595:Amino Acid Sequence; D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000737:chemistry* / Q000276:immunology / Q000378:metabolism; D000911:Antibodies, Monoclonal / Q000737:chemistry* / Q000276:immunology / Q000378:metabolism; D040761:Biomimetic Materials / Q000737:chemistry* / Q000378:metabolism; D022801:Complementarity Determining Regions; D015700:HIV Envelope Protein gp41 / Q000276:immunology*; D006801:Humans; D007143:Immunoglobulin Heavy Chains; D051379:Mice; D008958:Models, Molecular; D008969:Molecular Sequence Data; D011487:Protein Conformation; D015202:Protein Engineering / Q000379:methods*; D016415:Sequence Alignment; D057127:Single-Chain Antibodies
D016915:AIDS Vaccines; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D022801:Complementarity Determining Regions; D015700:HIV Envelope Protein gp41; D007143:Immunoglobulin Heavy Chains; D057127:Single-Chain Antibodies; C514787:gp41 protein, Human immunodeficiency virus 1